Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

NIH 5NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 9Prostatic Neoplasms 8Colorectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Melanoma 7Burkitt Lymphoma 6Pancreatic Neoplasms 5Lung Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Leukemia, Biphenotypic, Acute 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Wilms Tumor 3Osteosarcoma 3Malignant Solid Neoplasm 3Lymphoma, Non-Hodgkin 3Lymphoma 3Hematologic Neoplasms 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Rhabdomyosarcoma, Embryonal 2Recurrence 2

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sarcoma, Alveolar Soft Part × 30 days × Clear all
NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting
30 enrolled
BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡